Design Therapeutics, Inc. DSGN Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Design Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities.
The official record: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Design Therapeutics, Inc.'s change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Design Therapeutics, Inc.'s change in AP?
- Design Therapeutics, Inc. (DSGN) reported change in AP of -$2.51M in Q1 2026.
- How has Design Therapeutics, Inc.'s change in AP changed year-over-year?
- Design Therapeutics, Inc.'s change in AP decreased by 734.2% year-over-year, from -$301K to -$2.51M.
- What is the long-term trend for Design Therapeutics, Inc.'s change in AP?
- Over 2 years (2022 to 2025), Design Therapeutics, Inc.'s change in AP has grown at a -8.9% compound annual growth rate (CAGR), from $5.4M to $4.49M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.